Baird Medical Investment Holdings - Ordinary Share (BDMD) closed at $0.43 on October 26, 2026, down 3.9% from the previous close, on volume of 57,793 shares (30-day average 70,201).
Data as of October 26, 2026.
Globe Newswire (Mon, 19-Oct 8:00 AM ET)
Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
Globe Newswire (Mon, 5-Oct 8:00 AM ET)
Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Tue, 15-Sep 8:00 AM ET)
Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology
Globe Newswire (Mon, 14-Sep 8:00 AM ET)
Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
Globe Newswire (Thu, 3-Sep 8:00 AM ET)
Globe Newswire (Thu, 20-Aug 8:30 AM ET)
Globe Newswire (Mon, 10-Aug 8:30 AM ET)
Baird Medical’s Global AI Surgical Push: New Software Expansion Targets U.S., EU, and China
Market Chameleon (Wed, 4-Mar 6:59 AM ET)
Market Chameleon (Fri, 20-Feb 6:07 AM ET)
Market Chameleon (Thu, 19-Feb 5:36 AM ET)
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
Baird Medical Investment Holdings - Ordinary Share trades on the NASDAQ stock market under the symbol BDMD.
As of October 27, 2026, BDMD stock price declined to $0.27 with 543,951 million shares trading.
BDMD has a beta of 1.88, meaning it tends to be more sensitive to market movements. BDMD has a correlation of 0.03 to the broad based SPY ETF.
BDMD has a market cap of $8.67 million. This is considered a Sub-Micro Cap stock.
BDMD has underperformed the market in the last year with a price return of -80.7% while the SPY ETF gained +14.5%. BDMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -73.5% and -64.0%, respectively, while the SPY returned +4.2% and -1.3%, respectively.
BDMD support price is $.38 and resistance is $.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDMD shares will trade within this expected range on the day.
